Chinese stocks were largely range-bound on Monday as gains in technology shares offset losses in banks and insurers following Beijing’s $54 billion capital-injection plan. The Shanghai Composite slipped 0.2%, while the CSI300 gained 0.2%. Investors also monitored China-US relations, US rate expectations and semiconductor demand.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.